好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The 45-Minute Mark: Factors Driving Ultra-rapid Thrombolysis in a Dominican Republic Stroke Center
Cerebrovascular Disease and Interventional Neurology
P5 - Poster Session 5 (11:45 AM-12:45 PM)
4-006
To evaluate clinical and logistical factors linked to door-to-needle time (DTN) <45 minutes in a Dominican Republic tertiary center.

 Intravenous thrombolysis (IVT) improves outcomes in acute ischemic stroke (AIS); however, each minute of delay lessens the potential for neurological recovery. Achieving rapid treatment is therefore critical—patients treated within 45 minutes of arrival have significantly lower mortality, reduced disability, and fewer readmissions.

Retrospective, cross-sectional study of AIS patients receiving IVT between October 2022 and July 2025 (n=60). Sociodemographic, clinical, and operational variables were extracted from medical records. Descriptive and comparative analyses assessed predictors of DTN <45 vs ≥45 minutes, and a rapid IVT prediction model was generated using STATA 19.0.

Median age was 73.5 years (IQR 29.5), with 60% male. Median onset-to-door time (OTD) was 141.5 minutes (IRQ 80.5), door-to-imaging time (DTI) 25 minutes, and DTN 52 minutes; 48.3% achieved DTN <45 minutes. Emergency medical service (EMS) was the most frequent arrival mode in both groups. Each NIHSS point increased the odds of DTN <45 minutes by 68.9% (p=0.022), each OTD minute by 2.5% (p=0.005), and each year of age by 15% (p=0.003). In contrast, EMS arrival, and prior stroke reduced the odds of DTN <45 minutes by 98.2% (p=0.036) and 98.6% (p=0.041), respectively. Higher systolic blood pressure also lowered the odds by 9.9% per mmHg (p=0.02).

Higher NIHSS, older age, and longer OTD were associated with faster IVT, whereas EMS arrival, prior stroke, and elevated systolic blood pressure predicted DTN >45 minutes. These findings highlight the need to strengthen both prehospital and in-hospital processes, especially for patients with identifiable risk factors, to ensure timely and equitable acute stroke care.

Authors/Disclosures
Sabrina M. Lora, MD (CEDIMAT)
PRESENTER
Miss Lora has nothing to disclose.
María Cedeño-Bruzual, MD Dr. Cedeño-Bruzual has nothing to disclose.
Chanel Venecia Reyes Guzman, MD Dr. Reyes Guzman has nothing to disclose.
Marian A. Javier Mrs. Javier has nothing to disclose.
Francisco A. Mendez, Sr., MD Dr. Mendez has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Menarini.
Edwina L. Luna Rodríguez, MD (CEDIMAT) Dr. Luna Rodríguez has nothing to disclose.
Stephanie Castro Turbi, MD (CEDIMAT) Dr. Castro Turbi has nothing to disclose.